Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04995497
Other study ID # 202009510
Secondary ID
Status Completed
Phase Phase 2
First received
Last updated
Start date August 15, 2021
Est. completion date April 30, 2023

Study information

Verified date February 2024
Source University of Iowa
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Interfascial plane blocks have been developed for analgesia, among which the erector spinae plane (ESP) has gained popularity. The ESP block has been hypothesized to provide truncal analgesia by spread of local anesthetic into the paravertebral space. Recent studies have contested this idea showing unreliability in the spread of the local anesthetic into the paravertebral space.


Description:

Post-operative pain is a significant issue following open heart surgeries and poorly controlled pain can result in significant cardiorespiratory morbidity. Many patients suffer pain both at rest (49%) and on movement (62%) following open heart surgeries via sternotomy and adequate pain management requires closer re-assessment and treatment. The intensity of pain is noted to be higher in the first 48 hours post surgery and hence modalities to control pain may make the greatest difference in the first 2 days after surgery. Enhanced recovery pathways utilizing multimodal analgesia have shown significant analgesic and opioid sparing benefit while minimizing ICU and length of hospital stays. Some multimodal regimens have also incorporated regional blocks but the optimal analgesic regimen remains elusive. The ESP block has been hypothesized to provide truncal anesthesia by spread of local anesthetic into the paravertebral space, but recent studies contest this idea. Bilateral paravertebral blocks can result in higher than acceptable levels of local anesthetic in both cardiac and non-cardiac surgical patients and this may be true following bilateral erector spinae plane (ESP) as well. Hence, the pharmacokinetic profile of administered local anesthetics is necessary given the lack of information about the local anesthetic systemic levels following bilateral ESP.


Recruitment information / eligibility

Status Completed
Enrollment 70
Est. completion date April 30, 2023
Est. primary completion date April 7, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 69 Years
Eligibility Inclusion Criteria: - Undergoing elective cardiac surgery for coronary artery bypass graft (CABG) or valve surgery via sternotomy. - English speaking Exclusion Criteria: - Emergency surgery - Allergy to medications (ie lidocaine) - BMI less than 20 or greater than 35 - Major liver or kidney dysfunction or other pre-existing major organ dysfunction - Revision cardiac surgery - Surgery via thoracotomy - Off-pump coronary artery bypass - Narcotic dependent (Opioid intake morphine equivalents greater than 10mg/day for more than 3 months - Chronic pain (ie fibromyalgia) - Significant central nervous system or respiratory disease - Hematological disorders or de-ranged coagulation parameters - Psychiatric illness that impedes subject from providing informed consent - Pre-operative neurological deficits - Language barrier - Inability to provide informed consent - Prisoner status - Pregnancy

Study Design


Intervention

Drug:
Intravenous Administration of Lidocaine Post Cardiac Surgery
Lidocaine will be administered via intravenously. Initial dose will be at 2 mg/kg ideal body weight followed by dosing at 2 mg/kg/hr for 48 hours
Administration of Lidocaine Post Cardiac Surgery via ESP Catheter
Lidocaine will be administered via ESP catheter. Initial dose will be at 2 mg/kg ideal body weight split between two catheters followed by dosing at 2 mg/kg/hr for 48 hours

Locations

Country Name City State
United States University of Iowa Hospitals and Clinics Iowa City Iowa

Sponsors (1)

Lead Sponsor Collaborator
Archit Sharma

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Quantitate and report changes in pain scores reported by subject Pain scores will be recorded at baseline and at two hour intervals. The patients are asked to report their pain on a scale of 0 to 10 with 0 being no pain and 10 is the most imaginable. The variables will be presented as mean and standard deviation. First 2 days post surgical intervention
Primary Quantitate the amount of opioid medication required to provide pain relief To assess if either route (IV or ESP catheter) of lidocaine provided maximal pain relief when compared to its counterpart, the type and amount of medication provided the subject will be recorded. The amounts of opioid medications required to provide relief during the first 48 hours will be tabulated in morphine equivalents. A comparison will be made between the two route to see if one route is optimal over the other. The variables will be presented as mean and standard deviation. First 2 days post surgical intervention
See also
  Status Clinical Trial Phase
Completed NCT04110210 - Effectiveness of Bilateral Ultrasound-Guided Erector Spinae Plane Block Early Phase 1
Completed NCT03652103 - Efficiency of Erector Spinae Plane Block For Patients Undergoing Percutaneous Nephrolithotomy Phase 4
Recruiting NCT06088836 - Ultrasound- Guided Continuous Retro Laminar Block Versus Continuous Erector Spinae Plane Block in Multiple Rib Fractures N/A
Recruiting NCT04403360 - Erector Spinae Plane Block After Lumbar Spinal Stenosis Surgery N/A
Completed NCT05625009 - Bilateral Ultrasound-Guided Transversus Abdominis Plane (Tap) Block and Erector Spinal Plane (Esp) Block N/A
Not yet recruiting NCT06127966 - The Relationship Between NLR and PONV and ESPB Phase 1
Completed NCT06143020 - Effect of ESPB on Postoperative Pain in Patients With Breast Cancer Implant Reconstruction N/A
Recruiting NCT05158270 - Erector Spinae Plane Block As Alternative Analgesic Modality in Laparoscopic Cholecystectomy N/A
Not yet recruiting NCT04845711 - Ultrasound Guided Erector Spinae Plane Block Versus Quadratus Lumborum Block in Laparoscopic Cholecystectomy N/A
Recruiting NCT06377605 - The Efficacy of Thoracic Erector Spinae Plane Block For Perioperative Analgesia in Laparoscopic Bariatric Surgery for Super Obese Patients: Randomized Controlled Trial. N/A
Recruiting NCT06233617 - Dexamethasone vs. Dexmedetomidine for ESPB in Pain Management After Spine Surgery Phase 4
Not yet recruiting NCT04757480 - Thoracolumbar Interfascial Plane Block Versus Bilateral Erector Spinae Plane Block In Lumbar Laminectomy N/A
Active, not recruiting NCT04474873 - Effectivenes of Erector Spinae Plane Block in Percutaneous Nephrolithotomy? N/A
Recruiting NCT03887260 - Clinical Effectiveness of Erector Spinae Plane Block in Peri-operative Analgesia for Nephrectomy/Nephron Sparing Surgery(NSS) Performed Via Lumbotomy N/A
Completed NCT05083832 - Effect of Two Different Plane Blocks on Post-thoracotomy Pain N/A
Completed NCT05121727 - Comparison of Erector Spinae Plane Block and Combination of Deep and Superficial Serratus Anterior Plane Block N/A
Recruiting NCT05970380 - Effect of Erector Spinae Plane Block in Patients Scheduled for Kyphoplasty
Not yet recruiting NCT05409144 - Impact of Thoracic Epidural Versus Serratus Anterior Plane Block Versus Erector Spinae Plane Block on Incidence of PTPS N/A
Completed NCT03968146 - Erector Spinae Plane Block in Scoliotic Adolescents Phase 2
Not yet recruiting NCT06441071 - Patients' Positions on Analgesic Efficacy of ESPB N/A